TMV Capital focuses on investment in innovative technologies and business models with high growth potential, while also providing logistics services and wood processing.

TMV Capital

Person Schema

Gravatar Profiles

3 to 9 ccTLD Redirects

Nizar El Hachem

Jochen Knolle

Axel Polack

Marc Riviere

General Partner

Hubert Birner

Stefan Fischer

General Partner and Chief Financial Officer

Rolf Starck

Partner

Mirko Scherer

Managing Partner

Friedrich Bornikoel

Managing Director

Christoph Schröder

Luc Marengere

Arteris provides System IP for on-chip connectiviy, which improve performance, power consumption and die size of semiconductors.

Bluebird Bio is a biopharma company that develops and commercializes gene therapies for the treatment of severe genetic diseases and cancer.

TME Pharma develops biostable aptamers and substances based on mirror image nucleic acids.

Rapid Micro Biosystems offers tools that detect microbial contamination in manufacturing pharmaceutical, biotechnology and other products.

Argos Therapeutics develops immunotherapy treatments for cancers, infectious and autoimmune diseases, and transplantation rejection.

Concert Pharmaceuticals is a biotechnology company that uses deuterium chemistry to develop drug products that address patient needs.

ABIONYX Pharma is a biotech company discovering and developing innovative therapies for patients without existing or effective treatment.

F-Star Therapeutics is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.

Vivoryon is a clinical stage company focused on bringing first-in-class therapies to patients suffering from age-related diseases.

Newron Pharmaceuticals S.p.A. is a biopharmaceutical company

Venture Stage Investors with Investments in New England

Venture Stage Investors with Investments in Greater New York Area

Late Stage Venture Investors with Investments in New England

Venture Stage Investors with Investments in Europe

TVM Capital is a global venture and growth capital firm that aims to finance select biopharmaceutical and medical device companies.

TVM Capital was founded in 1983 and is based Munich, Bavaria.

TVM Life Science Ventures Vl

TVM V Life Science Ventures

Advertising, Business and Retail Services

Munich

Bayern

Germany

Europe

TVM Capital

Dubai's TVM Capital backs healthcare player from Saudi-focused fund

TVM Capital Healthcare Announces USD 35 Million Investment into Boston Oncology Arabia

TVM Capital Healthcare launches $250 million Saudi-focused Afiyah Fund

TVM Capital Healthcare Announces the Closing of its Saudi Arabia-Focused TVM Healthcare Afiyah Fund

TVM Capital raises $250 mln for Saudi healthcare fund

TVM Capital Healthcare Announces US$ 17 Million Investment into neurocare

TVM Capital Healthcare invests $ 17 million in Germany's neurocare

TVM Capital Healthcare invests in Vietnamese Eye Care Business Alina Vision in a Growth-Buy Out Transaction

United States

North America

Saudi Arabia

Asia

India

United Kingdom

HTML5

F5 NGINX

Office 365

Microsoft Outlook

Wordpress

Google Fonts

Apache Server

GoDaddy Premium DNS

Google Analytics

Gravity Forms

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 17, 2024 12:52 PM	91953049
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 17, 2024 12:52 PM	48899ecd
crunchbase trigger	general	Nov 22, 2024 7:44 AM	5e659103
crunchbase profile	general	Nov 22, 2024 9:15 AM	85de22ff
li profile	general
translate crunchbase fundingrounds	general	Nov 22, 2024 1:56 PM	1a631ca8
peers	general	Oct 17, 2024 12:52 PM	89e68b7b
news basic	general	Oct 17, 2024 12:52 PM	d42842b1
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:TMVCAPITAL

TMV Capital